NCT03759717Recruiting
Molecular and Cellular Characterization of Skull Base Tumors
Source: ClinicalTrials.gov · Last updated 25 Sept 2026
Brief summary (registry, in English)
The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 4000 (estimated)
- First submitted
- 31 Oct 2018
- Start date
- 3 Oct 2018
- Primary completion date
- 3 Oct 2028
- Lead sponsor
- University of Pittsburgh
- Diseases
- Childhood cancers
- NCT number
- NCT03759717
What you commit to
- Study type: Observational
- Planned participants: 4000
- From 3 Oct 2018 to the primary completion date, 3 Oct 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Insufficient tumor sample at time of resection
Who the study is looking for
- Diagnosis of a skull base tumor
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pittsburgh Medical Center Coordinator of this site? Confirm its status | Pittsburgh | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.